The principal sectors that make use of biotechnology are health, agriculture, and heavy industries. In this sphere, Brazil is as much of a market as it is a hub of development. It possesses the largest public health system in the world, attending more than 202 million people and consuming increasingly large numbers of products for chronic diseases. The country also possesses a competitive advantage in the production of biomass and is endowed with a rich level of biodiversity. Beyond its consistent results in scientific production, Brazil is the largest contributor to scientific articles related to biotechnology among the BRICs countries, equaling the average of OECD countries.
Biotechnology is therefore considered a strategic sector for the development of the Brazilian economy. The promotion of biotechnology has been a priority of the Brazilian government in the past years, as indicated by industrial policies put in place since 2004. Additionally, it is also considered a priority sector for policies of innovation, serving as a destination for funding from both the public and private sectors. Nevertheless, the companies that operate in the sector encounter challenges, such as the construction of legislation and regulatory frameworks, including ANVISA and CTnBio, and the carrying out of research using biogenetic resources.
As a result of innovation policies in the past years, a number of state-of-the-art laboratories have been created, guaranteeing the evolution of research and development in Brazil’s biotechnology field. The LNBIO, LNS, and CNPEM are examples of successful initiatives by different spheres of state and federal governments in partnership with universities.
In this context, multinational biotechnology companies have installed themselves in Brazil with the objective of furthering research and developing local industry in the process. In these cases, the companies attempt to adapt to local legislation that regulates the manipulation of micro-organisms and the access to biodiversity.
The actions of Prospectiva in the field of biotechnology assist some of the primary companies and sectorial associations to understand the construction of regulatory frameworks. Among the services provided are:
- Understanding of the political situation in specific areas related to innovation, biotechnology, and biodiversity;
- Designing business models;
- Structuring partnerships with government entities;
- Defense of interests across the three branches of government;
- Proposals of public policy;
- Support in negotiations.